Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug treatment of COVID-19 infection
Grace Lui, Giovanni Guaraldi
Current Opinion in Pulmonary Medicine (2023) Vol. 29, Iss. 3, pp. 174-183
Open Access | Times Cited: 30

Showing 1-25 of 30 citing articles:

A comprehensive review on pharmacological, toxicity, and pharmacokinetic properties of phillygenin: Current landscape and future perspectives
Cheng Wang, Rui Wu, Shenglin Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115410-115410
Open Access | Times Cited: 18
Alterations in microbiota of patients with COVID‐19: implications for therapeutic interventions
Yong Qiu, Chunheng Mo, Lu Chen, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 5
Unveiling COVID‐19 treatment strategies for immunocompromised individuals: Therapeutic innovations and latest findings
Li‐Teh Liu, Jih‐Jin Tsai
International Journal of Rheumatic Diseases (2024) Vol. 27, Iss. 1
Open Access | Times Cited: 4
Developing CAR-immune cell therapy against SARS-CoV-2: Current status, challenges and prospects
Yizhao Chen, Chong Liu, Yilong Fang, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116066-116066
Closed Access | Times Cited: 3
Pathogenic mechanisms of cardiovascular damage in COVID-19
Honghua Shao, Rui‐Xing Yin
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 3
Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors
Viviana De Luca, Andrea Angeli, Alessio Nocentini, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 971-971
Open Access | Times Cited: 2
COVID-19 Outcomes in Patients with Hematologic Malignancies in the Era of COVID-19 Vaccination and the Omicron Variant
Joaquín Martínez‐López, Javier de la Cruz, Rodrigo Gil-Manso, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 379-379
Open Access | Times Cited: 2
Consumption of Meats and Fish in Poland during the COVID-19 Lockdown Period
Dominika Szajnoga, Helena Perenc, Grzegorz K. Jakubiak, et al.
Nutrients (2024) Vol. 16, Iss. 9, pp. 1318-1318
Open Access | Times Cited: 1
A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of Concern
Michela Murdocca, Isabella Romeo, Gennaro Citro, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 891-891
Open Access | Times Cited: 1
Safety of High-Dose Vitamin C in Non-Intensive Care Hospitalized Patients with COVID-19: An Open-Label Clinical Study
Salvatore Corrao, Massimo Raspanti, Federica Agugliaro, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 13, pp. 3987-3987
Open Access | Times Cited: 1
In vitro cytotoxicity and antiviral activity of aminocaproic acid against SARS-CoV-2
Timur Saliev, Shynar Tanabayeva, Neilya Ussebayeva, et al.
Journal Of Advanced Pharmacy Education And Research (2024) Vol. 14, Iss. 3, pp. 1-8
Closed Access | Times Cited: 1
Management of patients with neurological diseases considering post‐pandemic coronavirus disease 2019 (COVID‐19) related risks and dangers — An updated European Academy of Neurology consensus statement
Saša R. Filipović, Şerefnur Öztürk, Dániel Bereczki, et al.
European Journal of Neurology (2024) Vol. 31, Iss. 10
Open Access | Times Cited: 1
High Throughput Screening for SARS-CoV-2 Helicase Inhibitors
Yuka Otsuka, Eunjung Kim, Austin Krueger, et al.
SLAS DISCOVERY (2024) Vol. 29, Iss. 6, pp. 100180-100180
Open Access | Times Cited: 1
Diagnosis and Critique of Drugs Used in Treating Coronavirus Disease in 2019 in Nigeria: A Review
Tajudeen Olusegun Rasheed, Wael Mohamed Noaman Higazy, Bilawu Yisa Abiodun
Pharmaceutical and Biomedical Research (2023) Vol. 9, Iss. 4, pp. 259-266
Open Access | Times Cited: 4
Adjuvants to the S1-subunit of the SARS-CoV-2 spike protein vaccine improve antibody and T cell responses and surrogate neutralization in mice
William Becker, Khadija Rebbani, Zhijian Duan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Drug-drug interactions between COVID-19 drug therapies and antidepressants
Efstathia Davoutis, C Panou, Nikolina Stachika, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 12, pp. 937-950
Closed Access | Times Cited: 3
Potential Drugs in COVID-19 Management
Amin Gasmi, Sàdaf Noor, Alain Menzel, et al.
Current Medicinal Chemistry (2023) Vol. 31, Iss. 22, pp. 3245-3264
Closed Access | Times Cited: 2
Advances in Curing Type 1 Diabetes: Stem Cell Therapy, Bioprinting, and Islet Transplantation
Bijaya Ghosh, Satarupa Acharjee, Akash Kr Samanta
Pharmaceutical and Biomedical Research (2023) Vol. 9, Iss. 4, pp. 267-288
Open Access | Times Cited: 2
Novel Advancements in COVID-19 and Neuroscience
Alessio Simonetti, Evelina Bernardi, Gabriele Sani
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 143-143
Open Access
Evaluating the Effect of Underlying Pulmonary Disease on the Clinical Outcome and survival among Patients with COVID-19: Using Propensity Score Matching
Malihe Safari, Fatemeh Ghadamgahi, Javad Faradmal, et al.
The Open Public Health Journal (2024) Vol. 17, Iss. 1
Open Access
Letter to the Editor: The role of vitamin D in the prevention and treatment of SARS-CoV-2 infection: A meta-analysis of randomized controlled trials
Arooj Fatima, Satesh Kumar, FNU Samiullah
Clinical Nutrition (2024) Vol. 43, Iss. 6, pp. 1663-1664
Closed Access
Exploring the Genetic Link Between COVID-19 Severity and Pre-eclampsia: The Role of NTSR1 Gene SNPs and Calcium Ion Transport
Linli Li, Qi Shen, Hui Zheng, et al.
Research Square (Research Square) (2024)
Open Access
Systematic Review: JAK-STAT Regulation and Its Impact on Inflammation Response in ARDS from COVID-19
I. Marín Rodríguez, Kate J. F. Carnevale
Immuno (2024) Vol. 4, Iss. 2, pp. 147-158
Open Access
Impact analysis of SARS-CoV-2 vaccination in patients treated with monoclonal antibodies: A monocentric experience
Nicola Perrotta, Luigi Angelo Fiorito, Cristiana Leanza, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113101-113101
Open Access
In Silico Evaluation of HIV Protease and RNA Polymerase Inhibitors as Potential COVID-19 Therapeutics
Mahalakshmi Devaraji, Lokeshvar Ravikumar
Cureus (2024)
Open Access
Page 1 - Next Page

Scroll to top